文献速递类风湿关节炎

类风湿关节炎中的肌少性肥胖:患病率及其对躯体功能的影响

Sarcopenic obesity in rheumatoid arthritis: prevalence and impact on physical functioning.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该研究基于三个RA队列,采用DXA测量的ALMI与FMI转换为年龄、性别和种族特异性Z评分,用新验证方法和传统方法分类体成分异常,并与两个参照人群比较。RA患者低瘦体重和肌少性肥胖患病率分别为14.2%和12.6%,高于参照人群的7-10%和4-4.5%(均P<0.05)。低瘦体重、肥胖和肌少性肥胖均与基线HAQ更高、SPPB更低相关,且随访中数值上恶化更明显。

要点

  • RA患者肌少性肥胖患病率12.6%,低瘦体重14.2%,均高于参照人群。
  • 新验证方法与传统方法对肌少性肥胖分类仅中度一致(Kappa 0.45)。
  • 低瘦体重、肥胖和肌少性肥胖均与基线躯体功能更差相关。

核心结论

  • RA患者低瘦体重和肌少性肥胖患病率高于一般人群。
  • 新验证的体成分分类方法与传统方法分类结果不同,且与躯体功能关联更强。
  • 低瘦体重、肥胖和肌少性肥胖均与基线HAQ更高和SPPB更低相关,随访中数值上恶化更明显。

研究设计与样本

  • 研究评估三个RA队列的数据,采用全身DXA测量的ALMI(kg/m2)和FMI,转换为年龄、性别和种族特异性Z评分。
  • 使用新验证方法与广泛使用的现有方法分类体成分,并与两个参照人群比较。
  • 在RA队列中,采用线性与逻辑回归评估体成分与随访HAQ变化及SPPB的关联,调整年龄、性别、种族和研究。

主要发现

  • RA患者低瘦体重患病率为14.2%,肌少性肥胖患病率为12.6%,参照人群分别为7-10%和4-4.5%(均P<0.05)。
  • 两种肌少性肥胖分类方法之间仅中度一致(Kappa 0.45)。
  • 新验证方法分类为肥胖的受试者更少,其中许多仅被分类为低瘦体重。
  • 低瘦体重、肥胖和肌少性肥胖均与基线HAQ更高和SPPB更低相关,且随访中数值上恶化更明显。

关键数值与推荐

  • 低瘦体重:RA患者14.2%,参照人群7-10%(P<0.05)。
  • 肌少性肥胖:RA患者12.6%,参照人群4-4.5%(P<0.05)。
  • 两种肌少性肥胖分类方法一致性Kappa 0.45。

临床怎么用

  • 对RA患者应关注体成分异常,尤其是低瘦体重和肌少性肥胖,因其与躯体功能更差相关。
  • 新验证的体成分分类方法可能更适用于评估RA患者躯体功能风险,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We determined the prevalence of sarcopenic obesity in patients with RA using multiple methods and assessed associations with physical functioning. METHODS: This study evaluated data from three RA cohorts. Whole-body dual-energy absorptiometry (DXA) measures of appendicular lean mass index (ALMI, kg/m2) and fat mass index (FMI) were converted to age, sex and race-specific Z-Scores and categorized using a recently validated method and compared it to a widely-used existing method. The prevalence of body composition abnormalities in RA was compared with two reference populations. In the RA cohorts, associations between body composition and change in the HAQ and the Short Physical Performance Battery (SPPB) in follow-up were assessed using linear and logistic regression, adjusting for age, sex, race and study. RESULTS: The prevalence of low lean mass and sarcopenic obesity was higher in patients with RA (14.2; 12.6%, respectively) compared with the reference population cohorts (7-10%; 4-4.5%, respectively, all P <0.05). There was only moderate agreement among methods of sarcopenic obesity categorization (Kappa 0.45). The recently validated method categorized fewer subjects as obese, and many of these were categorized as low lean mass only. Low lean mass, obesity and sarcopenic obesity were each associated with higher HAQ and lower SPPB at baseline and numerically greater worsening. CONCLUSION: RA patients had higher rates of low lean mass and sarcopenic obesity than the general population. The recently validated methods characterized body composition changes differently from traditional methods and were more strongly associated with physical function.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Baker JF, Giles JT, Weber D, et al. Sarcopenic obesity in rheumatoid arthritis: prevalence and impact on physical functioning. Rheumatology (Oxford). 2022. PMID: 34559201. doi:10.1093/rheumatology/keab710

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。